Literature DB >> 8041613

Mutagenesis in monkey cells of a vector containing a single d(GPG) cis-diamminedichloroplatinum(II) adduct placed on codon 13 of the human H-ras proto-oncogene.

M J Pillaire1, A Margot, G Villani, A Sarasin, M Defais, A Gentil.   

Abstract

Cisplatin (cis-[Pt(NH3)2Cl2]) is a widely used antitumor agent whose mutagenic activity raises the possibility of the induction of secondary cancer as a result of treatment. Mutation of the proto-oncogene H-ras is found in more than 30% of all human tumors, where it has been postulated to contribute to the initiation and progression of human cancers. Activating mutations in the H-ras gene are predominantly single-base substitutions, most frequently at codons 12, 13 and 61. In the present work we have studied the mutational spectra induced by a single cis-[Pt(NH3)2d(GpG)] adduct, the most frequent DNA crosslink formed by cisplatin. We have constructed a 25-mer-Pt oligonucleotide singly modified at codon 13 (GGT) within the human H-ras DNA sequence and we have inserted it into a single-stranded SV40-based shuttle vector able to replicate in simian COS7 cells. After replication in the mammalian host, vectors were extracted, amplified in bacteria and DNA from 124 randomly chosen colonies was sequenced. The observed mutation frequency was 21%. Base substitutions were the most frequent modification. 92% of the mutagenic events occurred at one or both of the platinated guanines of codon 13. The single G-->T transversion accounted for 65% of the total mutations scored. All single base substitutions were located at the G in the 3' position showing, for the first time, that the guanine at the 3' side of a cis-[Pt(NH3)2d(GpG)] adduct may be a preferential site for cisplatin induced mutations. The substitution G-->T at this position of the codon 13 of the H-ras proto-oncogene is known to induce the oncogenic properties of the p21ras protein.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8041613      PMCID: PMC308204          DOI: 10.1093/nar/22.13.2519

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  45 in total

1.  Mutagenic properties of a unique abasic site in mammalian cells.

Authors:  A Gentil; G Renault; C Madzak; A Margot; J B Cabral-Neto; J J Vasseur; B Rayner; J L Imbach; A Sarasin
Journal:  Biochem Biophys Res Commun       Date:  1990-12-14       Impact factor: 3.575

2.  Transcription by eucaryotic and procaryotic RNA polymerases of DNA modified at a d(GG) or a d(AG) site by the antitumor drug cis-diamminedichloroplatinum(II).

Authors:  Y Corda; C Job; M F Anin; M Leng; D Job
Journal:  Biochemistry       Date:  1991-01-08       Impact factor: 3.162

3.  Enhanced malignant conversion of benign mouse skin tumors by cisplatin.

Authors:  H Hennings; R A Shores; M C Poirier; E Reed; R E Tarone; S H Yuspa
Journal:  J Natl Cancer Inst       Date:  1990-05-16       Impact factor: 13.506

4.  Enchancement of the infectivity of simian virus 40 deoxyribonucleic acid with diethylaminoethyl-dextran.

Authors:  J H McCutchan; J S Pagano
Journal:  J Natl Cancer Inst       Date:  1968-08       Impact factor: 13.506

5.  Single d(ApG)/cis-diamminedichloroplatinum(II) adduct-induced mutagenesis in Escherichia coli.

Authors:  D Burnouf; C Gauthier; J C Chottard; R P Fuchs
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

6.  A d(GpG)-platinated decanucleotide duplex is kinked. An extended NMR and molecular mechanics study.

Authors:  F Herman; J Kozelka; V Stoven; E Guittet; J P Girault; T Huynh-Dinh; J Igolen; J Y Lallemand; J C Chottard
Journal:  Eur J Biochem       Date:  1990-11-26

7.  Analysis of mutations induced in the SUP4-o gene of Saccharomyces cerevisiae by cis-diammine dichloroplatinum(II).

Authors:  J R Mis; B A Kunz
Journal:  Carcinogenesis       Date:  1990-04       Impact factor: 4.944

Review 8.  Drugs five years later. Cisplatin.

Authors:  P J Loehrer; L H Einhorn
Journal:  Ann Intern Med       Date:  1984-05       Impact factor: 25.391

9.  Spectrum of cisplatin-induced mutations in Escherichia coli.

Authors:  D Burnouf; M Duane; R P Fuchs
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

10.  Studies on transformation of Escherichia coli with plasmids.

Authors:  D Hanahan
Journal:  J Mol Biol       Date:  1983-06-05       Impact factor: 5.469

View more
  8 in total

1.  Fork-like DNA templates support bypass replication of lesions that block DNA synthesis on single-stranded templates.

Authors:  J S Hoffmann; M J Pillaire; C Lesca; D Burnouf; R P Fuchs; M Defais; G Villani
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

2.  Replication bypass and mutagenic effect of alpha-deoxyadenosine site-specifically incorporated into single-stranded vectors.

Authors:  H Shimizu; R Yagi; Y Kimura; K Makino; H Terato; Y Ohyama; H Ide
Journal:  Nucleic Acids Res       Date:  1997-02-01       Impact factor: 16.971

3.  DNA polymerase beta bypasses in vitro a single d(GpG)-cisplatin adduct placed on codon 13 of the HRAS gene.

Authors:  J S Hoffmann; M J Pillaire; G Maga; V Podust; U Hübscher; G Villani
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

4.  Mutagenic and genotoxic effects of DNA adducts formed by the anticancer drug cis-diamminedichloroplatinum(II).

Authors:  K J Yarema; S J Lippard; J M Essigmann
Journal:  Nucleic Acids Res       Date:  1995-10-25       Impact factor: 16.971

5.  Solution structures of a DNA dodecamer duplex with and without a cisplatin 1,2-d(GG) intrastrand cross-link: comparison with the same DNA duplex containing an oxaliplatin 1,2-d(GG) intrastrand cross-link.

Authors:  Yibing Wu; Debadeep Bhattacharyya; Candice L King; Irene Baskerville-Abraham; Sung-Ho Huh; Gunnar Boysen; James A Swenberg; Brenda Temple; Sharon L Campbell; Stephen G Chaney
Journal:  Biochemistry       Date:  2007-05-12       Impact factor: 3.162

6.  Mammalian assay for site-specific DNA damage processing using the human H-ras proto-oncogene.

Authors:  L Arcangeli; K J Williams
Journal:  Nucleic Acids Res       Date:  1995-06-25       Impact factor: 16.971

7.  A comprehensive survey of the mutagenic impact of common cancer cytotoxics.

Authors:  Bernadett Szikriszt; Ádám Póti; Orsolya Pipek; Marcin Krzystanek; Nnennaya Kanu; János Molnár; Dezső Ribli; Zoltán Szeltner; Gábor E Tusnády; István Csabai; Zoltan Szallasi; Charles Swanton; Dávid Szüts
Journal:  Genome Biol       Date:  2016-05-09       Impact factor: 13.583

8.  Mechanism of double-base lesion bypass catalyzed by a Y-family DNA polymerase.

Authors:  Jessica A Brown; Sean A Newmister; Kevin A Fiala; Zucai Suo
Journal:  Nucleic Acids Res       Date:  2008-05-22       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.